Navigation Links
Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
Date:6/26/2008

ATLANTA, June 26 /PRNewswire/ -- Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported the interim month three safety and efficacy results from the first human pharmacokinetic (PK) study of Medidur(TM) FA, which Alimera Sciences intends to market under the tradename Iluvien(TM), if approved by the U.S. Food and Drug Administration.

This 36-month, open-label Phase 2 study, running concurrently with the pivotal Phase 3 FAME(TM) Study (Fluocinolone Acetonide in Diabetic Macular Edema), is designed primarily to assess systemic exposure of the corticosteroid, fluocinolone acetonide (FA), after administration of Iluvien in diabetic macular edema (DME) patients. Secondarily, the study is designed to provide information on the safety and efficacy of Iluvien in a DME population. A total of 37 subjects were enrolled in this trial, 20 patients on the low dose (an approximate 0.23 microgram per day dose) of Iluvien, and 17 patients on the high dose (an approximate 0.45 microgram per day dose) with the same inclusion/exclusion criteria as the ongoing Phase 3 FAME Study.

Iluvien is an intravitreal insert being developed for the treatment of DME. DME is a disease of the retina, which affects individuals with diabetes and can lead to severe vision loss and blindness. Each Iluvien insert is designed to provide a sustained therapeutic effect, up to 24 months for the low dose and up to 36 months for the high dose. Iluvien is inserted into the patient's eye with a 25-gauge needle, which allows for a self-sealing wound. This insertion is very similar to an intravitreal injection, a procedure commonly employed by retinal specialists.

This three-month interim readout from the PK Study indicated 20 percent of the low dose patients and 18 percent of the high dose patients showed an improvement in best-corrected visual acuity
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... KALAMAZOO, Mich., Dec. 3 /PRNewswire-FirstCall/ -...ay that its Board of Directors has authorized the ...mmon stock. The manner, timing and amount of any ...gement based on their evaluation of market conditi...ject to regulatory considerations. Purchases may ...
(Date:12/3/2009)... BEDFORD, Mass., Dec. 3 MicroCHIPS...ystems, today announced it has been named a 2010 T..., The company was selected for pioneering a nov...ponsive implants designed to bridge the gap betwee...echnologies have broad applicability, from ,rescue...
(Date:12/3/2009)..., MAPLE GROVE, Minn., Dec. 3 Up...next phase of its strategic plan for central nervo...ease topiramate), an internally developed program ...veloped with Upsher-Smith,s proprietary formulatio...rial in early 2010 for the adjunctive treatment of...
Breaking Medicine Technology:Stryker Announces $750 Million Share Repurchase Program and Declares a $0.15 Per Share Quarterly Dividend 2MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum 2Upsher-Smith Announces Milestone in Development of CNS Strategy 2Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 1Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 2Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 3Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 4Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 5Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 1Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 2Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 3Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 4The Healing Power of Art Dance and Expression 53374 1The Healing Power of Art Dance and Expression 53374 2The Healing Power of Art Dance and Expression 53374 3
...onference Status of Ongoing ...rm Retained, NOVATO, Calif., Sept. 13 Raptor,Pha...C Bulletin Board:,RPTP.OB) announced today that Dr...cer, will present a poster detailing promising pre...ts HepTide(TM) liver targeting,program at the Inte...
...ity,s expertise on diseases transmitted between an... symposium in Kansas City, Mo. Nearly half of the...security Symposium, Monday, Sept. 17, are affiliat... Convention and Entertainment Center, is being,org...tute. Drs. T.G. Nagaraja, Bob Rowland and Roman G...
Other Medicine Technology:Raptor Pharmaceuticals Provides Update of Product Programs 2Raptor Pharmaceuticals Provides Update of Product Programs 3Raptor Pharmaceuticals Provides Update of Product Programs 4Raptor Pharmaceuticals Provides Update of Product Programs 5Raptor Pharmaceuticals Provides Update of Product Programs 6K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security 2K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security 3
(Date:12/3/2009)... We are closer than ever before to...dable, quality care for all. The American Nurses ...epresentatives and voice their support for meaning...t: http://inr.mediaseed.tv/ANA_37124/ ,, Join...ocuses on wellness and prevention, a high-quality ...
(Date:12/3/2009)...rning of diabetes, cardiovascular disease, researc... News) -- Pregnant women who develop gestational g... risk for metabolic syndrome three months after th...glucose intolerance is less severe than gestationa...of factors (including high blood pressure, obesity...
(Date:12/3/2009)...ewswire-USNewswire/ -- The American Association fo...rom one of the largest studies to date on passive ...e Northern California Cancer Center (NCCC) . ,...d cigarettes and who were exposed to secondhand ci...dulthood--had a significantly increased breast can...
(Date:12/3/2009)...rstates key factors contributing to increases ,... new actuarial analysis by Oliver Wyman, Inc. find...dividual market will be 54 percent higher than the...lthcare reform under the Patient Protection and Af... medical inflation. This would translate into pre...
(Date:12/3/2009)...res on young women caused by outdated HPV test, no...cember 11 for blocking new technology. , ...009 -- Now the American College of Obstetricians ...cancer workup procedure, also known as colposcopi...e women who have received the procedure . However,...
Breaking Medicine News(10 mins):Health News:VIDEO from Medialink and the American Nurses Association (ANA): American Nurses Association Urges All Americans to Take Part in Health Care Reform Debate 2Health News:Blood Sugar Intolerance May Predict Postpartum Ills 2Health News:Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 3Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 4Health News:Harmful Procedures on Young Women Caused by Outdated HPV test, not by Pap Test 2
...lutions, an information,technology (IT) and Web pr...lth systems, announced today that it has won a cov...g (Extensive) market segment, as ranked by,healthc...re challenging, healthcare providers are,under tre...
...t longevity runs in families , , TUESDAY, ...lies, the saying goes, and new research shows ther... phenomenon. , The children of people who live to ...und. , But they aren,t impervious to non-cardiovas...
...Inc. announced it has,expanded its current product.... Zeus Insulated PEEK Wire is insulated copper wir...ations. Zeus, current capabilities consist,of extr...ature,excellent abrasion and chemical resistance, ...
...., a national healthcare management, technology, a...y, has been able to help the City of Newark, Ohio ...ing billed to insurance companies. , , After ...venues from insurance carriers for ambulance trans...
...ion,s largest union of,registered nurses today ann...g,Republican Senator Mitch McConnell for his Grinc...ustry unless unionized auto workers accept devasta... The campaign can be found HERE, http://ga1.org/c...
...eds.org, the most comprehensive source of informat... now has information on drug coupon programs. Thes... cost of drugs. , (Vocus)...ts can get free medications or rebates on purchase...
Other Medicine News:Health News:CareTech Solutions Named 'Best in KLAS' for Extensive IT Outsourcing Services 2Health News:Children of Centenarians Face Lower Heart Risks 2Health News:Children of Centenarians Face Lower Heart Risks 3Health News:Zeus Announces Product-Line Expansion with Insulated PEEK(TM) Wire 2Health News:City of Newark, Ohio Increases Safety Services with EMS Revenue Recovered by MED3OOO EMS Billing 2Health News:City of Newark, Ohio Increases Safety Services with EMS Revenue Recovered by MED3OOO EMS Billing 3Health News:'The Mitch Who Stole Christmas' 2Health News:NeedyMeds.org Offers Information on Drug Discount Coupon 2
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: